Crinetics Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript - Thomson StreetEvents

Crinetics Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript

Crinetics Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript - Thomson StreetEvents
Crinetics Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Published Jan 15, 2025
10 pages (7186 words) — Published Jan 15, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of CRNX.OQ presentation 15-Jan-25 12:30am GMT

  
Brief Excerpt:

...Great. Welcome, everyone. My name is Jess Fye. I'm a biotech analyst at JPMorgan, and we are continuing the 43rd Annual Healthcare Conference today with Crinetics. You're going to hear a presentation from the company's CEO, and then we'll go into some Q&A. (Conference Instructions) But with that, let me pass it over to Crinetics' CEO, Scott Struthers. R. Scott Struthers ...

  
Report Type:

Transcript

Source:
Company:
Crinetics Pharmaceuticals Inc
Ticker
CRNX.OQ
Time
12:30am GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Jessica Fye - JPMorgan - Analyst : Great. Thanks for the presentation. So you provided us an update on the Phase II for atumelnant last week and a bit of a stark reaction in the stock. Can you take us through each of the cases of elevated liver enzymes that you saw and just kind of like just level set the information there?


Question: Jessica Fye - JPMorgan - Analyst : Got it. And no interest in bilirubin?


Question: Jessica Fye - JPMorgan - Analyst : And was there any anything liver related in the preclinical data?


Question: Jessica Fye - JPMorgan - Analyst : Got it. So as we think about what could be shaping up to be a differentiated clinical efficacy profile for this product, what do you see as kind of the optimal development plan to really showcase the product?


Question: Jessica Fye - JPMorgan - Analyst : Great. So you're heading into this milestone approval for Crinetics, expecting your first product approval with paltusotine later this year. What's a reasonable framework to think about the peak sales opportunity there in acromegaly? And how should we think about the path to get there?


Question: Jessica Fye - JPMorgan - Analyst : Little time left. When could we hear Crinetics reveal more about your efforts in the oral GLP-1 space?


Question: Jessica Fye - JPMorgan - Analyst : Okay. Great. I think we're out of time. So thank you. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. JANUARY 15, 2025 / 12:30AM, CRNX.OQ - Crinetics Pharmaceuticals Inc at JPMorgan Healthcare Conference

Table Of Contents

Crinetics Pharmaceuticals Inc Q2 2025 Earnings Call Transcript – 2025-08-07 – US$ 54.00 – Edited Transcript of CRNX.OQ earnings conference call or presentation 7-Aug-25 8:30pm GMT

Crinetics Pharmaceuticals Inc R&D Day Transcript – 2025-06-26 – US$ 54.00 – Edited Transcript of CRNX.OQ corporate analyst meeting</ 26-Jun-25 1:00pm GMT

Crinetics Pharmaceuticals Inc Q1 2025 Earnings Call Transcript – 2025-05-08 – US$ 54.00 – Edited Transcript of CRNX.OQ earnings conference call or presentation 8-May-25 8:30pm GMT

Crinetics Pharmaceuticals Inc at TD Cowen Healthcare Conference Transcript – 2025-03-03 – US$ 54.00 – Edited Transcript of CRNX.OQ presentation 3-Mar-25 4:10pm GMT

Crinetics Pharmaceuticals Inc Q4 2024 Earnings Call Transcript – 2025-02-27 – US$ 54.00 – Edited Transcript of CRNX.OQ earnings conference call or presentation 27-Feb-25 9:30pm GMT

Crinetics Pharmaceuticals Inc Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia Call Transcript – 2025-01-10 – US$ 54.00 – Edited Transcript of CRNX.OQ conference call or presentation 10-Jan-25 1:30pm GMT

Crinetics Pharmaceuticals Inc at Citi Global Healthcare Conference Transcript – 2024-12-04 – US$ 54.00 – Edited Transcript of CRNX.OQ presentation 4-Dec-24 2:30pm GMT

Crinetics Pharmaceuticals Inc Q3 2024 Earnings Call Transcript – 2024-11-12 – US$ 54.00 – Edited Transcript of CRNX.OQ earnings conference call or presentation 12-Nov-24 9:30pm GMT

Crinetics Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript – 2024-09-04 – US$ 54.00 – Edited Transcript of CRNX.OQ presentation 4-Sep-24 9:35pm GMT

Crinetics Pharmaceuticals Inc Q2 2024 Earnings Call Transcript – 2024-08-08 – US$ 54.00 – Edited Transcript of CRNX.OQ earnings conference call or presentation 8-Aug-24 8:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Crinetics Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript" Jan 15, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Crinetics-Pharmaceuticals-Inc-at-JPMorgan-Healthcare-Conference-T16220552>
  
APA:
Thomson StreetEvents. (2025). Crinetics Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript Jan 15, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Crinetics-Pharmaceuticals-Inc-at-JPMorgan-Healthcare-Conference-T16220552>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.